Koninklijke Philips N.V. (PHIA.AS)
EUR 24.19
(1.51%)
EUR 24.19
(1.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.63 Billion EUR | 1.34% |
| 2022 | 17.4 Billion EUR | 5.57% |
| 2021 | 16.48 Billion EUR | 4.27% |
| 2020 | 15.81 Billion EUR | 10.13% |
| 2019 | 14.35 Billion EUR | 3.28% |
| 2018 | 13.9 Billion EUR | 4.59% |
| 2017 | 13.29 Billion EUR | -29.28% |
| 2016 | 18.79 Billion EUR | -2.09% |
| 2015 | 19.19 Billion EUR | 10.42% |
| 2014 | 17.38 Billion EUR | 13.38% |
| 2013 | 15.33 Billion EUR | -14.37% |
| 2012 | 17.9 Billion EUR | 8.01% |
| 2011 | 16.57 Billion EUR | -3.49% |
| 2010 | 17.17 Billion EUR | 8.15% |
| 2009 | 15.88 Billion EUR | -1.94% |
| 2008 | 16.19 Billion EUR | 10.64% |
| 2007 | 14.63 Billion EUR | -4.74% |
| 2006 | 15.36 Billion EUR | -8.79% |
| 2005 | 16.84 Billion EUR | 8.23% |
| 2004 | 15.56 Billion EUR | -2.9% |
| 2003 | 16.03 Billion EUR | -11.94% |
| 2002 | 18.2 Billion EUR | -8.2% |
| 2001 | 19.83 Billion EUR | 21.08% |
| 2000 | 16.38 Billion EUR | 13.38% |
| 1999 | 14.44 Billion EUR | 5.97% |
| 1998 | 13.63 Billion EUR | -19.16% |
| 1997 | 16.86 Billion EUR | -7.68% |
| 1996 | 18.26 Billion EUR | -1.44% |
| 1995 | 18.53 Billion EUR | 17.11% |
| 1994 | 15.82 Billion EUR | 3.24% |
| 1993 | 15.32 Billion EUR | -15.28% |
| 1992 | 18.09 Billion EUR | 12.98% |
| 1991 | 16.01 Billion EUR | -3.59% |
| 1990 | 16.61 Billion EUR | 4.88% |
| 1989 | 15.83 Billion EUR | 2.28% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | - EUR | -100.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 17.55 Billion EUR | 0.0% |
| 2023 Q2 | 17.34 Billion EUR | 0.0% |
| 2023 Q4 | 17.34 Billion EUR | 0.0% |
| 2023 FY | 17.63 Billion EUR | 1.34% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q2 | 17.72 Billion EUR | 0.0% |
| 2022 FY | 17.4 Billion EUR | 5.57% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q4 | 17.4 Billion EUR | 0.0% |
| 2021 Q4 | 16.48 Billion EUR | 0.0% |
| 2021 FY | 16.48 Billion EUR | 4.27% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 17.02 Billion EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 FY | 15.81 Billion EUR | 10.13% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 16.5 Billion EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 Q4 | 15.81 Billion EUR | 0.0% |
| 2019 Q2 | 14.42 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 14.35 Billion EUR | 0.0% |
| 2019 FY | 14.35 Billion EUR | 3.28% |
| 2019 Q3 | - EUR | -100.0% |
| 2018 Q4 | 13.9 Billion EUR | 0.0% |
| 2018 FY | 13.9 Billion EUR | 4.59% |
| 2018 Q2 | 13.12 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 17.7 Billion EUR | 12.91% |
| 2017 FY | 13.29 Billion EUR | -29.28% |
| 2017 Q1 | 17.83 Billion EUR | -5.11% |
| 2017 Q2 | 15.68 Billion EUR | -12.07% |
| 2017 Q4 | 13.29 Billion EUR | -24.93% |
| 2016 Q2 | 18.74 Billion EUR | 2.16% |
| 2016 Q1 | 18.34 Billion EUR | -4.42% |
| 2016 Q4 | 18.79 Billion EUR | 1.94% |
| 2016 FY | 18.79 Billion EUR | -2.09% |
| 2016 Q3 | 18.43 Billion EUR | -1.64% |
| 2015 Q1 | 20.29 Billion EUR | 16.76% |
| 2015 FY | 19.19 Billion EUR | 10.42% |
| 2015 Q2 | 19.37 Billion EUR | -4.54% |
| 2015 Q4 | 19.19 Billion EUR | 3.01% |
| 2015 Q3 | 18.63 Billion EUR | -3.82% |
| 2014 Q1 | 14.94 Billion EUR | -2.5% |
| 2014 FY | 17.38 Billion EUR | 13.38% |
| 2014 Q2 | 14.9 Billion EUR | -0.32% |
| 2014 Q3 | 16.91 Billion EUR | 13.54% |
| 2014 Q4 | 17.38 Billion EUR | 2.75% |
| 2013 Q2 | 16.82 Billion EUR | -4.03% |
| 2013 Q4 | 15.33 Billion EUR | -6.36% |
| 2013 Q1 | 17.52 Billion EUR | -2.1% |
| 2013 FY | 15.33 Billion EUR | -14.37% |
| 2013 Q3 | 16.37 Billion EUR | -2.67% |
| 2012 Q4 | 17.9 Billion EUR | 5.35% |
| 2012 Q2 | 17.03 Billion EUR | -1.82% |
| 2012 Q1 | 17.34 Billion EUR | 4.65% |
| 2012 Q3 | 16.99 Billion EUR | -0.21% |
| 2012 FY | 17.9 Billion EUR | 8.01% |
| 2011 Q2 | 14.02 Billion EUR | -11.52% |
| 2011 Q1 | 15.85 Billion EUR | -7.73% |
| 2011 FY | 16.57 Billion EUR | -3.49% |
| 2011 Q3 | 14.77 Billion EUR | 5.33% |
| 2011 Q4 | 16.57 Billion EUR | 12.22% |
| 2010 Q3 | 16.61 Billion EUR | -10.26% |
| 2010 FY | 17.17 Billion EUR | 8.15% |
| 2010 Q4 | 17.17 Billion EUR | 3.36% |
| 2010 Q2 | 18.51 Billion EUR | 7.61% |
| 2010 Q1 | 17.2 Billion EUR | 8.34% |
| 2009 FY | 15.88 Billion EUR | -1.94% |
| 2009 Q3 | 15.97 Billion EUR | 1.94% |
| 2009 Q2 | 15.67 Billion EUR | -5.34% |
| 2009 Q1 | 16.55 Billion EUR | -1.16% |
| 2009 Q4 | 15.88 Billion EUR | -0.59% |
| 2008 Q1 | 17.66 Billion EUR | 20.67% |
| 2008 Q2 | 14.98 Billion EUR | -15.16% |
| 2008 Q3 | 15.87 Billion EUR | 5.95% |
| 2008 FY | 16.19 Billion EUR | 10.64% |
| 2008 Q4 | 16.75 Billion EUR | 5.49% |
| 2007 Q4 | 14.63 Billion EUR | 0.95% |
| 2007 Q2 | 14.33 Billion EUR | -5.88% |
| 2007 Q1 | 15.23 Billion EUR | -0.9% |
| 2007 FY | 14.63 Billion EUR | -4.74% |
| 2007 Q3 | 14.5 Billion EUR | 1.17% |
| 2006 FY | 15.36 Billion EUR | -8.79% |
| 2006 Q1 | 17 Billion EUR | 0.94% |
| 2006 Q3 | 15.41 Billion EUR | -3.27% |
| 2006 Q4 | 15.36 Billion EUR | -0.31% |
| 2006 Q2 | 15.93 Billion EUR | -6.29% |
| 2005 Q1 | 15.52 Billion EUR | -0.28% |
| 2005 Q4 | 16.84 Billion EUR | 5.91% |
| 2005 Q2 | 15.27 Billion EUR | -1.61% |
| 2005 FY | 16.84 Billion EUR | 8.23% |
| 2005 Q3 | 15.9 Billion EUR | 4.15% |
| 2004 Q4 | 15.56 Billion EUR | -1.63% |
| 2004 Q2 | 16.75 Billion EUR | -3.93% |
| 2004 Q1 | 17.44 Billion EUR | 8.77% |
| 2004 FY | 15.56 Billion EUR | -2.9% |
| 2004 Q3 | 15.82 Billion EUR | -5.54% |
| 2003 FY | 16.03 Billion EUR | -11.94% |
| 2003 Q4 | 16.03 Billion EUR | -6.06% |
| 2003 Q3 | 17.06 Billion EUR | -0.58% |
| 2003 Q2 | 17.16 Billion EUR | -5.98% |
| 2003 Q1 | 18.25 Billion EUR | 0.28% |
| 2002 Q1 | 20.24 Billion EUR | 2.06% |
| 2002 Q2 | 18.79 Billion EUR | -7.17% |
| 2002 Q3 | 19.17 Billion EUR | 2.02% |
| 2002 Q4 | 18.2 Billion EUR | -5.02% |
| 2002 FY | 18.2 Billion EUR | -8.2% |
| 2001 FY | 19.83 Billion EUR | 21.08% |
| 2001 Q4 | 19.83 Billion EUR | 0.43% |
| 2001 Q3 | 19.74 Billion EUR | 11.42% |
| 2001 Q2 | 17.72 Billion EUR | 1.73% |
| 2001 Q1 | 17.42 Billion EUR | 6.36% |
| 2000 Q3 | 16.49 Billion EUR | 9.28% |
| 2000 Q2 | 15.09 Billion EUR | -0.3% |
| 2000 Q1 | 15.13 Billion EUR | 4.79% |
| 2000 Q4 | 16.38 Billion EUR | -0.7% |
| 2000 FY | 16.38 Billion EUR | 13.38% |
| 1999 Q2 | 13.47 Billion EUR | -0.84% |
| 1999 Q4 | 14.44 Billion EUR | 5.94% |
| 1999 Q3 | 13.63 Billion EUR | 1.21% |
| 1999 Q1 | 13.58 Billion EUR | -0.33% |
| 1999 FY | 14.44 Billion EUR | 5.97% |
| 1998 FY | 13.63 Billion EUR | -19.16% |
| 1998 Q3 | 13.25 Billion EUR | -1.13% |
| 1998 Q2 | 13.4 Billion EUR | -20.12% |
| 1998 Q1 | 16.78 Billion EUR | -0.45% |
| 1998 Q4 | 13.63 Billion EUR | 2.83% |
| 1997 FY | 16.86 Billion EUR | -7.68% |
| 1997 Q4 | 16.86 Billion EUR | -10.97% |
| 1997 Q3 | 18.94 Billion EUR | 0.39% |
| 1997 Q2 | 18.86 Billion EUR | -1.0% |
| 1997 Q1 | 19.05 Billion EUR | 4.34% |
| 1996 Q4 | 18.26 Billion EUR | 0.0% |
| 1996 FY | 18.26 Billion EUR | -1.44% |
| 1995 Q4 | 18.53 Billion EUR | 0.0% |
| 1995 FY | 18.53 Billion EUR | 17.11% |
| 1994 FY | 15.82 Billion EUR | 3.24% |
| 1994 Q4 | 15.82 Billion EUR | 0.0% |
| 1993 FY | 15.32 Billion EUR | -15.28% |
| 1993 Q4 | 15.32 Billion EUR | 0.0% |
| 1992 Q4 | 18.09 Billion EUR | 0.0% |
| 1992 FY | 18.09 Billion EUR | 12.98% |
| 1991 FY | 16.01 Billion EUR | -3.59% |
| 1991 Q4 | 16.01 Billion EUR | 0.0% |
| 1990 FY | 16.61 Billion EUR | 4.88% |
| 1990 Q4 | 16.61 Billion EUR | 0.0% |
| 1989 Q4 | 15.83 Billion EUR | 0.0% |
| 1989 FY | 15.83 Billion EUR | 2.28% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Affluent Medical SA | 25.15 Million EUR | -70032.4% |
| Bluelinea Société Anonyme | 8.86 Million EUR | -198880.202% |
| Carmat SA | 96.83 Million EUR | -18116.274% |
| Diagnostic Medical Systems S.A. | 37.41 Million EUR | -47042.934% |
| Euromedis Groupe | 23.66 Million EUR | -74429.857% |
| Eurobio Scientific Société anonyme | 141.15 Million EUR | -12396.015% |
| Ikonisys S.A. | 5.11 Million EUR | -344415.083% |
| Implanet S.A. | 10.81 Million EUR | -163057.895% |
| Median Technologies SA | 46.22 Million EUR | -38056.529% |
| SpineGuard SA | 5 Million EUR | -352440.061% |
| Theraclion SA | 13.01 Million EUR | -135411.9% |
| Euroapi S.A. | 684.7 Million EUR | -2476.165% |
| Guerbet SA | 646.97 Million EUR | -2626.402% |
| Ion Beam Applications SA | 490.44 Million EUR | -3496.522% |
| Sequana Medical NV | 29.56 Million EUR | -59559.325% |